Skip to main content

Published locations for CV outcomes of SGLT2 inhibitors and GLP-1 agonists compared in real-world study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CV outcomes of SGLT2 inhibitors and GLP-1 agonists compared in real-world study

User login

  • Reset your password
  • /content/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real-world-study
  • /clinicianreviews/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared
  • /familypracticenews/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared
  • /fedprac/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real-world
  • /internalmedicinenews/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists
  • /clinicalendocrinologynews/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists
  • /diabeteshub/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real
  • /ecardiologynews/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared
  • /cardiology/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real
  • /endocrinology/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real
  • /internalmedicine/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared
  • /familymedicine/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists-compared-real
  • /type-2-diabetes-icymi/article/223871/diabetes/cv-outcomes-sglt2-inhibitors-and-glp-1-agonists